Specifically, Balversa is approved to treat patients whose cancer has susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations and who have progressed after at least one line of systemic therapy
Decision points: At 8 weeks, evaluate
In the U.S., tirzepatide is available under the brand names Zepbound (FDA approved for chronic weight management in eligible adults) and Mounjaro (FDA approved to improve blood sugar in adults with type 2 diabetes)
Adhering to a prescribed dosage schedule is essential for maintaining consistency
Indeed, in the author's laboratory, a systematic search of fractionated (gel and high-performance liquid chromatography) extracts of the duodenal mucosa was carried out using GLP-1 secretion from isolated perfused ileum as bioassay, but no unknown GLP-1 stimulating agents could be identified (95, 99)
GLP-1 Cost Management, Coverage, and Demand Skyrocketing costs are one challenge